| Dr Susan D Osada, DC | |
|
13 1/2 Eagle St, Suite G, Asheville, NC 28801-3794 | |
| (828) 301-2383 | |
| Not Available |
| Full Name | Dr Susan D Osada |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 28 Years |
| Location | 13 1/2 Eagle St, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598080103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111NN1001X | Chiropractor - Nutrition | 2501 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inspire Chiropractic And Wellness | 7618265356 | 3 |
News Archive
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The increase in single-parent families was a dramatic social change of the 20th century.
A new viewpoint article published in the journal JAMA Pediatrics in April 2020 discusses the manifestation and management of the novel coronavirus disease devastating several countries.
› Verified 3 days ago
| Provider Name | Doctors Making Housecalls Family Medicine,pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275773087 PECOS PAC ID: 1153473723 Enrollment ID: O20090806000567 |
News Archive
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The increase in single-parent families was a dramatic social change of the 20th century.
A new viewpoint article published in the journal JAMA Pediatrics in April 2020 discusses the manifestation and management of the novel coronavirus disease devastating several countries.
› Verified 3 days ago
| Provider Name | Inspire Chiropractic & Wellness |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255885893 PECOS PAC ID: 7618265356 Enrollment ID: O20161012000313 |
News Archive
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The increase in single-parent families was a dramatic social change of the 20th century.
A new viewpoint article published in the journal JAMA Pediatrics in April 2020 discusses the manifestation and management of the novel coronavirus disease devastating several countries.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan D Osada, DC 312 Union St S, Concord, NC 28025-5018 Ph: (828) 301-2383 | Dr Susan D Osada, DC 13 1/2 Eagle St, Suite G, Asheville, NC 28801-3794 Ph: (828) 301-2383 |
News Archive
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The increase in single-parent families was a dramatic social change of the 20th century.
A new viewpoint article published in the journal JAMA Pediatrics in April 2020 discusses the manifestation and management of the novel coronavirus disease devastating several countries.
› Verified 3 days ago
Gentle Family Chiropractic Center, P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 82 Arlington St, Asheville, NC 28801 Phone: 828-253-8900 Fax: 828-505-1974 | |
Hardin Chiropractic, P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 91 Mount Carmel Rd, Asheville, NC 28806 Phone: 828-505-3905 Fax: 828-505-4158 | |
Dr. Stanley Setzer Ii, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 91 Mount Carmel Rd, Asheville, NC 28806 Phone: 828-775-0260 Fax: 828-505-4158 | |
Dr. Eric Seth Shapiro, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1089 Hendersonville Rd, Asheville, NC 28803 Phone: 828-274-9799 Fax: 828-274-7737 | |
Matthew Glynn Dc, Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 183 Bartlett St Ste 120, Asheville, NC 28801 Phone: 828-253-5844 | |
Gary Walicki, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 22 Sardis Rd, Asheville, NC 28806 Phone: 828-667-8000 Fax: 828-667-8001 | |
Andrew Senzon, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 218 E Chestnut St, Asheville, NC 28801 Phone: 828-251-0815 |